Zobrazeno 1 - 10 of 64 pro vyhledávání: '"Sarai, Palanca"'
1
Akademický článek
RET Fusion Testing in Patients With NSCLC: The RETING Study
Autor: Esther Conde, MD, PhD, Susana Hernandez, PhD, Jose Luis Rodriguez Carrillo, MD, Rebeca Martinez, APT, Marta Alonso, APT, Daniel Curto, MD, Beatriz Jimenez, MD, Alejandra Caminoa, MD, PhD, Amparo Benito, MD, Pilar Garrido, MD, PhD, Sergi Clave, PhD, Edurne Arriola, MD, PhD, Isabel Esteban-Rodriguez, MD, PhD, Javier De Castro, MD, PhD, Irene Sansano, MD, Enriqueta Felip, MD, PhD, Federico Rojo, MD, PhD, Manuel Dómine, MD, PhD, Ihab Abdulkader, MD, PhD, Jorge Garcia-Gonzalez, MD, Cristina Teixido, PhD, Noemi Reguart, MD, PhD, Desamparados Compañ, MD, PhD, Amelia Insa, MD, Nuria Mancheño, MD, PhD, Sarai Palanca, MD, PhD, Oscar Juan-Vidal, MD, PhD, Nuria Baixeras, MD, Ernest Nadal, MD, PhD, Maria Cebollero, MD, Antonio Calles, MD, Paloma Martin, MD, PhD, Clara Salas, MD, PhD, Mariano Provencio, MD, PhD, Ignacio Aranda, MD, PhD, Bartomeu Massuti, MD, Laura Lopez-Vilaro, MD, Margarita Majem, MD, PhD, Luis Paz-Ares, MD, PhD, Fernando Lopez-Rios, MD, PhD
Publikováno v: JTO Clinical and Research Reports, Vol 5, Iss 4, Pp 100653- (2024)
Introduction: RET inhibitors with impressive overall response rates are now available for patients with NSCLC, yet the identification of RET fusions remains a difficult challenge. Most guidelines encourage the upfront use of next-generation sequencin
Externí odkaz: https://doaj.org/article/a3e58ca9d39948fda3972ff1d75a8f34
Zobrazit plný text záznamu
3
Akademický článek
Implementation of massive sequencing in the genetic diagnosis of hereditary cancer syndromes: diagnostic performance in the Hereditary Cancer Programme of the Valencia Community (FamCan-NGS)
Autor: Marta Ramírez-Calvo, Zaida García-Casado, Antonio Fernández-Serra, Inmaculada de Juan, Sarai Palanca, Silvestre Oltra, José Luis Soto, Adela Castillejo, Víctor M Barbera, Ma José Juan-Fita, Ángel Segura, Isabel Chirivella, Ana Beatriz Sánchez, Isabel Tena, Carolina Chaparro, Dolores Salas, José Antonio López-Guerrero
Publikováno v: Hereditary Cancer in Clinical Practice, Vol 17, Iss 1, Pp 1-7 (2019)
Abstract Background Approximately 5 to 10% of all cancers are caused by inherited germline mutations, many of which are associated with different Hereditary Cancer Syndromes (HCS). In the context of the Program of Hereditary Cancer of the Valencia Co
Externí odkaz: https://doaj.org/article/59943a328e9e4837b9229c49cbe8b25d
Zobrazit plný text záznamu
4
Akademický článek
Utility of Next-Generation Sequencing in the Reconstruction of Clonal Architecture in a Patient with an EGFR Mutated Advanced Non-Small Cell Lung Cancer: A Case Report
Autor: Javier Simarro, Gema Pérez-Simó, Nuria Mancheño, Carlos Francisco Muñoz-Núñez, Enrique Cases, Óscar Juan, Sarai Palanca
Publikováno v: Diagnostics, Vol 12, Iss 5, p 1266 (2022)
EGFR tyrosine kinase inhibitors (EGFR-TKIs) have revolutionized the treatment of non-small cell lung cancer (NSCLC) patients with activating EGFR mutations. However, targeted therapies impose a strong selective pressure against the coexisting tumor p
Externí odkaz: https://doaj.org/article/ca4e61345fcb4f6394c6f155c2e1d440
Zobrazit plný text záznamu
5
Akademický článek
Towards Personalized Medicine in Melanoma: Implementation of a Clinical Next-Generation Sequencing Panel
Autor: Blanca de Unamuno Bustos, Rosa Murria Estal, Gema Pérez Simó, Inmaculada de Juan Jimenez, Begoña Escutia Muñoz, Mercedes Rodríguez Serna, Victor Alegre de Miquel, Margarita Llavador Ros, Rosa Ballester Sánchez, Eduardo Nagore Enguídanos, Sarai Palanca Suela, Rafael Botella Estrada
Publikováno v: Scientific Reports, Vol 7, Iss 1, Pp 1-11 (2017)
Abstract Molecular diagnostics are increasingly performed routinely in the diagnosis and management of patients with melanoma due to the development of novel therapies that target specific genetic mutations. The development of next-generation sequenc
Externí odkaz: https://doaj.org/article/e39afa7edb1547ada0b0f991d05e9aec
Zobrazit plný text záznamu
8
MicroRNAs expression associated with aggressive clinicopathological features and poor prognosis in primary cutaneous melanomas
Autor: Javier Simarro Farinos, Rosa Ballester Sánchez, Margarita Ros, Rosa Murria Estal, Ignacio Torres Navarro, Victor Alegre de Miquel, Sarai Palanca Suela, Rafael Botella Estrada, Gema Pérez Simó, Vicente Sabater Marco, Blanca de Unamuno Bustos
Publikováno v: MELANOMA RESEARCH
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Several studies have focused on identifying microRNAs involved in the pathogenesis of melanoma. However, its association with clinicopathological features has been scarcely addressed. The aim of this study is to identify microRNAs expression profiles
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bf1afae94bea39d1ef132eb6963b051
https://doi.org/10.1097/cmr.0000000000000709
Zobrazit plný text záznamu
9
Design and Validation of a Custom Next-Generation Sequencing Panel in Pediatric Acute Lymphoblastic Leukemia
Autor: José Vicente Gil, Esperanza Such, Claudia Sargas, Javier Simarro, Alberto Miralles, Gema Pérez, Inmaculada de Juan, Sarai Palanca, Gayane Avetisyan, Marta Santiago, Carolina Fuentes, José María Fernández, Ana Isabel Vicente, Samuel Romero, Marta Llop, Eva Barragán
Publikováno v: International Journal of Molecular Sciences
Volume 24
Issue 5
Pages: 4440
The molecular landscape of acute lymphoblastic leukemia (ALL) is highly heterogeneous, and genetic lesions are clinically relevant for diagnosis, risk stratification, and treatment guidance. Next-generation sequencing (NGS) has become an essential to
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd230897aa770022597533c39ac0e872
https://doi.org/10.3390/ijms24054440
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje